26 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
completion of its acquisition of Apexigen, Inc. (“Apexigen”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative
425
7ax473 rf
25 May 23
Business combination disclosure
8:14am
425
9xhz3f 5w
24 May 23
Business combination disclosure
5:00pm
425
EX-99.1
1mtyg
24 May 23
Business combination disclosure
4:55pm
8-K
EX-99.1
0hh6xdja07dykokoh61z
24 May 23
Regulation FD Disclosure
4:53pm
425
22he9
24 May 23
Business combination disclosure
7:05am
425
vl7cpl0743
24 May 23
Business combination disclosure
7:03am
8-K
EX-99.1
hvryxyqs10eu3fuq7vb
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
8-K
EX-99.1
co64i1uw m0vxd39
15 Aug 22
Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities
7:11am
10-K
h0rvz7bliilpm
29 Mar 22
Annual report
7:36am
10-Q
tig23cjt
15 Nov 21
Quarterly report
7:54am
424B4
ihqaozcjina
8 Oct 21
Prospectus supplement with pricing info
5:00pm